TNFRSF21 anticorps (AA 371-655)

N° du produit ABIN7173876

L’anticorps anti-TNFRSF21 Polyclonal Lapin est utilisé pour la détection de TNFRSF21 dans des échantillons de Humain. Il a été validé pour WB, ELISA et IHC.

Aperçu rapide pour TNFRSF21 anticorps (AA 371-655) (ABIN7173876)

Antigène: TNFRSF21 (Tumor Necrosis Factor Receptor Superfamily, Member 21 (TNFRSF21))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TNFRSF21 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Détail du produit anti-TNFRSF21 anticorps

Épitope: AA 371-655

Fonction: TNFRSF21 Antibody

Purification: Antigen Affinity Purified

Immunogène: Recombinant Human Tumor necrosis factor receptor superfamily member 21 protein (371-655AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur TNFRSF21

Antigène: TNFRSF21 (Tumor Necrosis Factor Receptor Superfamily, Member 21 (TNFRSF21))

Autre désignation: TNFRSF21

Sujet:

Background: Promotes apoptosis, possibly via a pathway that involves the activation of NF-kappa-B. Can also promote apoptosis mediated by BAX and by the release of cytochrome c from the mitochondria into the cytoplasm. Plays a role in neuronal apoptosis, including apoptosis in response to amyloid peptides derived from APP, and is required for both normal cell body death and axonal pruning. Trophic-factor deprivation triggers the cleavage of surface APP by beta-secretase to release sAPP-beta which is further cleaved to release an N-terminal fragment of APP (N-APP). N-APP binds TNFRSF21, this triggers caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6). Negatively regulates oligodendrocyte survival, maturation and myelination. Plays a role in signaling cascades triggered by stimulation of T-cell receptors, in the adaptive immune response and in the regulation of T-cell differentiation and proliferation. Negatively regulates T-cell responses and the release of cytokines such as IL4, IL5, IL10, IL13 and IFNG by Th2 cells. Negatively regulates the production of IgG, IgM and IgM in response to antigens. May inhibit the activation of JNK in response to T-cell stimulation.

Aliases: TNFRSF 21 antibody, BM 018 antibody, BM018 antibody, CD358 antibody, Death receptor 6 antibody, DR 6 antibody, DR6 antibody, MGC31965 antibody, OTTHUMP00000039915 antibody, TNFR related death receptor 6 antibody, TNFRSF21 antibody, TNFRSF21 protein antibody, TNR21_HUMAN antibody, Tumor necrosis factor receptor superfamily member 21 antibody, Tumor necrosis factor receptor superfamily member 21 precursor antibody

UniProt: O75509

Pathways: Regulation of Lipid Metabolism by PPARalpha